COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
75.42 EUR
+0.02 (+0.03%)
CBHD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 64 industry peers in the Health Care Equipment & Supplies industry. While CBHD has a great profitability rating, there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively. Finally CBHD also has an excellent dividend rating. These ratings would make CBHD suitable for dividend investing!
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
In the past year CBHD had a positive cash flow from operations.
Each year in the past 5 years CBHD has been profitable.
In the past 5 years CBHD always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.52%, CBHD belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
CBHD has a Return On Equity of 22.55%. This is amongst the best in the industry. CBHD outperforms 88.89% of its industry peers.
CBHD has a better Return On Invested Capital (12.65%) than 92.06% of its industry peers.
CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 9.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROIC | 12.65% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
1.3 Margins
CBHD has a better Profit Margin (13.04%) than 76.19% of its industry peers.
In the last couple of years the Profit Margin of CBHD has declined.
The Operating Margin of CBHD (27.52%) is better than 95.24% of its industry peers.
CBHD's Operating Margin has declined in the last couple of years.
The Gross Margin of CBHD (67.97%) is better than 74.60% of its industry peers.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% |
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CBHD is creating value.
The number of shares outstanding for CBHD remains at a similar level compared to 1 year ago.
The number of shares outstanding for CBHD has been increased compared to 5 years ago.
CBHD has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.91 indicates that CBHD is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.91, CBHD is doing good in the industry, outperforming 68.25% of the companies in the same industry.
CBHD has a debt to FCF ratio of 4.34. This is a neutral value as CBHD would need 4.34 years to pay back of all of its debts.
The Debt to FCF ratio of CBHD (4.34) is comparable to the rest of the industry.
CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
CBHD's Debt to Equity ratio of 1.24 is on the low side compared to the rest of the industry. CBHD is outperformed by 84.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Altman-Z | 3.91 |
ROIC/WACC2.23
WACC5.66%
2.3 Liquidity
A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
CBHD has a Current ratio (1.61) which is in line with its industry peers.
CBHD has a Quick Ratio of 1.00. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
CBHD has a Quick ratio (1.00) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased strongly by -20.93% in the last year.
The Earnings Per Share has been decreasing by -2.02% on average over the past years.
Looking at the last year, CBHD shows a small growth in Revenue. The Revenue has grown by 3.12% in the last year.
CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
3.2 Future
Based on estimates for the next years, CBHD will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.78% on average per year.
CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.08% yearly.
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 31.69, CBHD can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CBHD is on the same level as its industry peers.
CBHD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.54.
Based on the Price/Forward Earnings ratio of 21.60, the valuation of CBHD can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as CBHD.
CBHD's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.69 | ||
| Fwd PE | 21.6 |
4.2 Price Multiples
CBHD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 60.32% of the companies in the same industry.
74.60% of the companies in the same industry are more expensive than CBHD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.69 | ||
| EV/EBITDA | 15.35 |
4.3 Compensation for Growth
CBHD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CBHD may justify a higher PE ratio.
CBHD's earnings are expected to grow with 21.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y27.18%
EPS Next 3Y21.46%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.08%, CBHD is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.24, CBHD pays a better dividend. On top of this CBHD pays more dividend than 96.83% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.96, CBHD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.08% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
CBHD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP136.36%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
FRA:CBHD (12/12/2025, 7:00:00 PM)
75.42
+0.02 (+0.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.27%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap15.85B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70
Price Target92.6 (22.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.08% |
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-0.16%
PT rev (3m)-3.58%
EPS NQ rev (1m)7.53%
EPS NQ rev (3m)17.67%
EPS NY rev (1m)0.81%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)5.95%
Revenue NQ rev (3m)8.83%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-1.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.69 | ||
| Fwd PE | 21.6 | ||
| P/S | 4.25 | ||
| P/FCF | 22.69 | ||
| P/OCF | 17.82 | ||
| P/B | 7.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.35 |
EPS(TTM)2.38
EY3.16%
EPS(NY)3.49
Fwd EY4.63%
FCF(TTM)3.32
FCFY4.41%
OCF(TTM)4.23
OCFY5.61%
SpS17.75
BVpS10.27
TBVpS-8.72
PEG (NY)0.68
PEG (5Y)N/A
Graham Number23.45
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| ROCE | 18.32% | ||
| ROIC | 12.65% | ||
| ROICexc | 12.94% | ||
| ROICexgc | 47.68% | ||
| OM | 27.52% | ||
| PM (TTM) | 13.04% | ||
| GM | 67.97% | ||
| FCFM | 18.72% |
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.24 | ||
| Debt/FCF | 4.34 | ||
| Debt/EBITDA | 2.2 | ||
| Cap/Depr | 98.21% | ||
| Cap/Sales | 5.12% | ||
| Interest Coverage | 9.3 | ||
| Cash Conversion | 72.84% | ||
| Profit Quality | 143.51% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.91 |
F-Score6
WACC5.66%
ROIC/WACC2.23
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.93%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-20.03%
EPS Next Y46.87%
EPS Next 2Y27.18%
EPS Next 3Y21.46%
EPS Next 5Y16.78%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%0.1%
Revenue Next Year5.02%
Revenue Next 2Y6.25%
Revenue Next 3Y6.66%
Revenue Next 5Y7.08%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.63%
EBIT Next 3Y14.66%
EBIT Next 5Y12.28%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%
COLOPLAST-B / CBHD.DE FAQ
What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE.
What is the valuation status for CBHD stock?
ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.
Can you provide the financial health for CBHD stock?
The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.
What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?
The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.87% in the next year.